title: [Sarcoidosis-like reaction after treatment with doxorubicin, bleomycin, vinblastine and dacarbazine in a patient with Hodgkin's lymphoma].
authors: Anna
authors: A
authors: Torrent
authors: Jose Tomas
authors: JT
authors: Navarro
authors: Felipe Cristobal
authors: FC
authors: Andreo
authors: Josep-María
authors: JM
authors: Ribera
mesh_terms: D000209:Acute-Phase Proteins / Q000032:analysis; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects; D003606:Dacarbazine / Q000008:administration & dosage / Q000009:adverse effects; D003937:Diagnosis, Differential; D018450:Disease Progression; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D005189:False Positive Reactions; D005260:Female; D006099:Granuloma / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis / Q000000981:diagnostic imaging; D006689:Hodgkin Disease / Q000150:complications / Q000000981:diagnostic imaging* / Q000188:drug therapy; D006801:Humans; D008199:Lymphadenitis / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis / Q000000981:diagnostic imaging; D064847:Multimodal Imaging; D049268:Positron-Emission Tomography; D012507:Sarcoidosis / Q000175:diagnosis; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed; D014747:Vinblastine / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D000209:Acute-Phase Proteins; D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin